Pandey 2010.
Methods | Parallel RCT |
Participants | Fewer than 2 superficial haemangiomas less than 5 cm Age: unclear Sex: unclear Country: unclear |
Interventions | Topical steroid (mometasone furoate) given twice daily versus intralesional steroid (triamcinolone acetonide), injected at monthly intervals using 24‐gauge needle at doses of 1 to 2 mg/kg |
Outcomes |
Primary outcome:
Secondary outcome:
Complications (including irritation, hypopigmentation, pain, bleeding, infection, cutaneous atrophy, Cushingoid facies, and growth retardation) |
Notes |
GLUT1: glucose transporter 1; MRI: magnetic resonance imaging; PHACE syndrome: posterior fossa malformations–haemangiomas–arterial anomalies–cardiac defects–eye abnormalities syndrome; PICC line: peripherally inserted central catheter; RCT: randomised controlled trial; RIH: refractory infantile haemangiomas.